Yüklüyor......
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia
Treatment of acute myeloid leukaemia (AML) is challenging and emerging treatment options include protein phosphatase 2A (PP2A) activators. Fingolimod is a known PP2A activator that inhibits multiple signalling pathways and has been used extensively in patients with multiple sclerosis and other indic...
Kaydedildi:
| Yayımlandı: | Anticancer Drugs |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams & Wilkins
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4881728/ https://ncbi.nlm.nih.gov/pubmed/26967515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000358 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|